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The functional relationship between the detection of carbapenemase activity and
phenotypic resistance in Gram-negative bacterial pathogens is often ill-defined. To
address this issue, we developed a two-tiered Modified Hodge Test approach for
carbapenemase detection and typing, in which the use of Pseudomonas aeruginosa
strain PAO1 and Escherichia coli as indicator strains conferred two levels of sensitivities
to carbapenemases. When applied alongside PCR genotyping tests for existence of
known carbapenemase genes in 92 carbapenem resistant clinical isolates, this method
is extremely useful in elucidating the relative role by which different enzymes contributed
to the prevalent carbapenem-resistance phenotypes. With this study approach, we
showed that the proportion of P. aeruginosa and Acinetobacter baumannii strains
whose carbapenem resistance phenotypes could at least be partially attributed to
carbapenemase were 34 and 89%, respectively. Our data also facilitates detailed
functional categorization of carbapenem resistance phenotypes on the basis of the
types and activities of detectable carbapenemase produced by the test organism.
For example, six A. baumannii isolates harboring the blaOXA 51/23-like gene without−
detectable enzymatic activities were identified, suggesting that other resistance
mechanisms may be involved. On the other hand, there were seven P. aeruginosa strains
which produced carbapenemase phenotype without harboring known carbapenemase
genes, inferring the existence of some hitherto unknown resistance determinants.
Findings in this work therefore provide a comprehensive view on the cellular basis of
carbapenem resistance phenotypes in major Gram-negative bacterial species, paving
the way for development of novel strategies to reverse the effects of the major resistance
mechanisms concerned.
Keywords: Pseudomonas aeruginosa, Acinetobacter baumannii, carbapenem resistance, two-tiered Modified
Hodge Test, genotyping
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Introduction
Dissemination of carbapenem-resistant organisms continues to
cause an increasing number of severe and often untreatable bac-
terial infections in nosocomial settings (Woodford et al., 2014).
Production of active carbapenemase is a major carbapenem resis-
tance mechanism among clinical Gram-negative isolates. There
are several major classes of carbapenemase, including Class A
serine carbapenemases such as Klebsiella pneumoniae carbapen-
emase (KPC), Class B metallo-β-lactamase such as New Delhi
metallo-β-lactamse (NDM), Verona integron-encoded metallo-
β-lactamase (VIM), IMP, and Carbapenem-hydrolyzing Class D
β-lactamases (CHDL) such as OXA-48, OXA-23, OXA-24, etc.
Nordmann et al. (2011). In addition, OXA-51 has been reported
to be intrinsic to Acinetobacter baumannii and it normally does
not lead to carbapenem resistance unless an Insertion Sequence,
ISAba1, is introduced into its upstream region, enhancing the
strength of the promoter and causing over-expression of the
oxa-51 gene. Even if this happens, it has been reported that
the CHDL OXA-51 produced exhibits only weak carbapenemase
activity (Turton et al., 2006). Determination of the presence of
carbapenemase activity is pivotal for clinicians to devise a suitable
treatment regimen. To date, several enzymatic- and inhibitor-
based phenotypic assays have been developed for detection of
bacterial carbapenemase activities. Enzymatic assays, includ-
ing Modiﬁed Hodge Test (MHT) and Carba NP test, involve
the direct observation of carbapenmase hydrolysing phenotype
in the presence of an indicator organism or a pH indicator
(Nordmann et al., 2012b). Inhibitor assays which include com-
mercially available E test MBL Strip (Nordmann et al., 2012a)
and the Imipenem/EDTA inhibition test, deploy chemicals such
as EDTA, a metal chelator, to inhibit enzyme activity, and are
mainly used for detecting Metallo-β-lactamase (MBL) activity.
Above all, MHT is a recommended method for identifying car-
bapenemase producers (CLSI, 2013). However, this method is not
ideal for detection of CHDL, including OXA-51, OXA-23, and
OXA-58 in Acinetobacter (Dortet et al., 2014). OXA-51 is intrin-
sic to A. baumannii and normally does not lead to carbapenem
resistance, thus it is regarded as a less active carbapenemase,
unless it is over-expressed by introduction of a strong promoter
in its upstream region as a result of insertion of the inser-
tion sequence ISAba1(Turton et al., 2006). Detection of other
CHDLs such as OXA-23 and OXA-58 inA. baumannii has always
been a challenge due to the low membrane permeability of the
organisms (Dortet et al., 2014). Failure to detect carbapenemases
produced by clinical strains is a serious concern since false cat-
egorization of the corresponding resistant organisms may result
in wrong diagnosis and ineﬀective treatment. Although perfor-
mance of Pseudomonas aeruginosa as an indicator strain in MHT
to detect MBLs was found to be unsatisfactory previously due to
the low speciﬁcity of this method and its high tendency to pro-
duce intermediate results (Pasteran et al., 2011), the suitability
of this test approach to detect CHDLs has not been evalu-
ated. In this work, replacement of Escherichia coli ATCC25922
by P. aeruginosa PAO1 as the indicator strain was found to
signiﬁcantly improve sensitivity in detection of less active car-
bapenemase producers. We showed that combined analysis of
results of carbapenemase detection tests with MHT and PAO1–
MHT, which cover detection sensitivity toward CHDLs and other
carbapenemases, as well as those of PCR genotyping of carbapen-
emase genes, allows highly accurate assessment of the type and
relative role of the carbapenemase involved in conferring the
observable phenotype. This analytical approach shall therefore
help better deﬁne the molecular basis of clinical carbapenem
resistance and establish a proﬁle of carbapenemase-encoding ele-
ments commonly harbored by each of the key Gram-negative
pathogens. Such data are essential for future development of
novel antimicrobial strategies, especially those involved in car-
bapenemase inhibition.
Materials and Methods
Bacterial Isolates
A total of 102 clinical isolates were collected from patients in
The Prince of Wales Hospital, Hong Kong (n = 27), and Henan
Provincial People’s Hospital, Henan, China (n = 75). The collec-
tion comprised A. baumannii (n = 68), P. aeruginosa (n = 32),
Enterobacter cloacae (n = 1) and E. coli (n = 1). Four P. otitidis
isolates recovered from food products were also included as con-
trol (Table 1). The isolates were identiﬁed by the Vitek Bacterial
Identiﬁcation System, followed by 16SrRNA sequencing.
Antimicrobial Susceptibility Testing
Antimicrobial susceptibility assay was performed and interpreted
according to the CLSI guidelines (CLSI, 2013). Antimicrobial sus-
ceptibility testing was carried out by the agar dilution method
with meropenem and imipenem as the test agents. Results were
interpreted following the CLSI guidelines (CLSI, 2013). E. coli
strains ATCC25922, 35218, and P. aeruginosa strain ATCC27853
were used as quality control.
PCR Detection of Carbapenemase Genes
Possession of carbapenemase genes by isolates was investi-
gated by PCR as described previously (Woodford et al., 2006;
Poirel et al., 2011; Thaller et al., 2011; Lopes et al., 2012).
The PCR assays included detection of blaOXA−23, blaOXA−24,
blaOXA−51, blaOXA−58, blaIMP, blaVIM, blaOXA, blaSIM, blaKPC,
blaSPM, blaDIM, blaGIM, blaNDM, and blaPOM. Primers used in this
study are shown in Table 1. Genomic DNAwas obtained by using
the Purelink Genomic Mini Kit (Life Technologies). 1 μl of DNA
template was added into PCR reaction mix (1X PCRBuﬀer, 3 mM
MgCl2, 0.2 mM dNTP, 0.25 μM primer, 1U Takara rTaq). The
assays were validated by including a pET15B vector carrying tar-
get constructs as positive control, and amplicons were subjected
to sequencing.
Two-Tiered Modified Hodge Test
Modiﬁed Hodge Test for meropenem was performed on all iso-
lates as described using the E. coli strain ATCC25922 and P.
aeruginosa strain PAO1 as indicator organisms (designated as
MHT and MHT-PAO1, respectively), and a blaIMP-producing
E. coli strain as positive control. Meropenem susceptibility test-
ing disks were obtained from Oxoid, and Mueller-Hinton Agar
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TABLE 1 | Primers used in this study.
β-lactamase Forward sequence (5′–3′) Reverse sequence (5′–3′) Amplicon size (bp) Reference
blaOXA−51 TAATGCTTTGATCGGCCTTG TGGATTGCACTTCATCTTGG 353 Woodford et al. (2006)
blaOXA−23 GATCGGATTGGAGAACCAGA ATTTCTGACCGCATTTCCAT 501
blaOXA−24 GGTTAGTTGGCCCCCTTAAA AGTTGAGCGAAAAGGGGATT 246
blaOXA−58 AAGTATTGGGGCTTGTGCTG CCCCTCTGCGCTCTACATAC 599
blaIMP GGAATAGAGTGGCTTAAYTCTC GGTTTAAYAAAACAACCACC 232 Poirel et al. (2011)
blaVIM GATGGTGTTTGGTCGCATA CGAATGCGCAGCACCAG 390
blaOXA GCGTGGTTAAGGATGAACAC CATCAAGTTCAACCCAACCG 438
blaSIM TACAAGGGATTCGGCATCG TAATGGCCTGTTCCCATGTG 570
blaKPC CGTCTAGTTCTGCTGTCTTG CTTGTCATCCTTGTTAGGCG 798
blaSPM AAAATCTGGGTACGCAAACG ACATTATCCGCTGGAACAGG 271
blaDIM GCTTGTCTTCGCTTGCTAACG CGTTCGGCTGGATTGATTTG 699
blaGIM TCGACACACCTTGGTCTGAA AACTTCCAACTTTGCCATGC 477
blaNDM GGTTTGGCGATCTGGTTTTC CGGAATGGCTCATCACGATC 621
blaPOM ACGTCGCTGATGCTCAG CCTGCGTCATCAGAGACCTC 1143 Thaller et al. (2011)
(MHA) was obtained from BD. Indicator organisms and test
isolates were grown overnight on MHA. Bacterial suspension of
indicated organism at 0.5 McFarland Standard was prepared by
saline and spread on MHA plates on which meropenem disks
(10 μg, Oxoid) were placed at center. Inoculated plates were
allowed to dry for 10 min followed by streaking a line of test
strains with a 10 μl inoculation loop from the drug disk to the
edge of agar plate. Results were recorded after 18 h incubation
at 37◦C. Production of active carbapenemases was regarded as
positive upon observation of “clover-leaf” appearance due to
enhanced growth of indicator strain toward the meropenem disk
alongside the test strain.
Results and Discussion
A total of 106 strains (102 clinical isolates and four food isolates)
were ﬁrst subjected to antibiotic susceptibility tests. Among the
68 A. baumannii isolates tested, 52 were resistant to meropenem
and imipenem. The rest of the test strains, including 32 P. aerug-
inosa isolates, four P. Otitis isolates, one Enterobacter cloacae
strain, and one E. coli strain, were all carbapenem resistant.
PCR genotyping experiments showed that known carbapenemase
genes were not detectable in as many as 28 carbapenem resis-
tant P. aeruginosa strains. The other four strains were found
to contain the blaIMP (three strains) and blaKPC genes (one
strain), respectively. MHT tests were then performed to assess
the degree of correlation between existence of carbapenemase
genes and the detection of carbapenemase activity, with results
indicating that the carbapenemase blaIMP was detectable by both
MHT tests, yet the blaKPC enzyme was detectable by MHT-
PAO1 only (Figure 1). Despite such discrepancy, the four host
strains concerned all exhibited high level meropenem resistance
(≥32 μg/ml), suggesting that active carbapenemase production
might not be the sole basis of carbapenem resistance in these
organisms. Likewise, 5 of the 28 P. aeruginosa strains which
did not harbor any known carbapenemase gene were found to
produce a carbapenemase phenotype detectable by MHT–PAO1
only; in addition, another two strains were found to produce an
enzyme detectable by both MHT tests (Figure 1). Although false
positives have been described in MHT to detect carbapenemases
in P. aeruginosa previously, it can not rule out the possibility that
other unknown carbapenem resistance mechanisms are present
in these seven strains (Vasoo et al., 2013). Table 2 summarizes
the results of genotyping, MHT tests and antibiotic susceptibility
levels of the 106 strains studied in this work. For carbapenem-
resistant P. aeruginosa, MHT–POA1 can detect 100% (4/4) of
know carbapenemase producers and 25% (7/28) of isolates with-
out known carbapenemase genes, while MHT can detect 75%
(3/4) of know carbapenemase producers and 7% (2/28) of isolates
without known carbapenemase genes.
Of the 68 A. baumannii isolates tested, 17 were found
to contain the intrinsic blaOXA−51-like CHDL-producing gene
only, among which were the 14 carbapenem-sensitive strains.
Interestingly, the ISAba1 element was detectable in the upstream
region of a blaOXA−51-like gene in the other three of these 17
strains, which were also found to produce a carbapenemase
detectable only by MHT–PAO1, corroborating with the fact
that the ISAba1 element is essential for over-expression of the
blaOXA−51-like gene. The remaining 51 isolates were found to
harbor other carbapenemase-producing genetic elements, with
the vast majority (49 strains) containing the blaOXA−51/23-like
gene. Among these 49 strains, whose meropenem MIC ranged
from 8 to≥32μg/ml, 16 were positive in bothMHT tests, 27 were
positive in the MHT-PAO1 only, and six strains did not produce
any detectable carbapenemases (Figure 1). These ﬁndings appear
to suggest that blaOXA−51/23-like gene product may not be the
sole factor responsible for the development of the carbapenem
resistance phenotypes of the organisms concerned.
The other two of the 51 isolates which harbored carbapen-
emase genes included one highly resistant strain (meropenem
MIC ≥ 32 μg/ml) which contained a blaOXA−51/24-like ele-
ment. However, this strain was tested positive only in MHT-
PAO1, again suggesting the involvement of non-carbapenemase
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FIGURE 1 | Result of Modified Hodge Test for representative
isolates. (A) Modified Hodge Test (MHT–PAO1 of three blaIMP−borne
Pseudomonas aeruginosa strains (left, upper, right) with an Escherichia
coli strain harboring the blaIMP gene as positive control (bottom).
(B) MHT–PAO1 of three blaOXA−23-borne Acinetobacter baumannii strains
(left, upper, right) with an E. coli strain harboring the blaIMP gene as
positive control (bottom). (C) MHT (Left) and MHT-PAO1 (right) of a
blaPOM-borne P. otitidis strain (E1-7). (D) MHT (Left) and MHT-PAO1 (right)
of a blaOXA−23–borne A. baumannii strain (CP51). Arrows indicate
enhanced growth of indicator organism.
mechanisms. Likewise, another strain which contained both the
blaOXA−51-like and blaNDM genes, exhibited a meropenem MIC
of ≥32 μg/ml, which is signiﬁcantly higher than that observed in
the three strains containing the blaOXA−51-like gene alone, plus
an ISAba1 element (8 μg/ml). Such discrepancy highlighted the
additive eﬀects of diﬀerent enzymes on the strength of phenotypic
carbapenem resistance. It should be noted that the phenomenon
of high level carbapenem resistance and low level enzyme pro-
duction was also observable in a meropenem-resistant E. coli
strain harboring the blaNDM gene in this study, as well as sev-
eral E. coli and K. pneumoniae isolates described previously
(Girlich et al., 2012). This phenomenon suggests the possibility
that the level of carbapenem resistance exhibited by a given clin-
ical isolate is more closely related to the type rather than level
of carbapenemase produced by the organism. Alternatively, these
ﬁndings could also indicate that the blaNDM enzyme might only
confer relatively low level carbapenem resistance, and other fac-
tors including altered membrane permeability and expression of
eﬄux may be responsible for the high level carbapenem resis-
tance phenotypes exhibited by the host strains concerned. This
possibility is also raised by the ﬁnding that the meropenem MIC
of an Enterobacter cloacae strain, which harbored the blaNDM
and blaKPC genes and exhibited a positive result in both MHT
tests, was only16 μg/ml. On the other hand, blaPOM, encoding
an intrinsic Metallo-β-Lactamase, was detected in all the four P.
otitidis isolates (Table 2). This enzyme, which was consistently
detectable by the MHT–PAO1 test only, was associated with a
meropenem MIC of 16–≥32 μg/ml. These ﬁndings suggest a
need to investigate the role of each speciﬁc carbapenemase in
conferring carbapenem resistance in the host strain. In summary,
within 60 isolates of carbapenem-resistant P. otitidis, h coli, and
K. pneumonia, 90% (54/60) were positive for MHT–POA1 test,
while only 26% (16/60) were positive for MHT testing.
In this work, MHT–PAO1 yielded 63 carbapenemase-positive
cases whereas MHT yielded 22 positive cases, with MHT–PAO1
being much more sensitive in detecting CHDL in A. baumannii,
as well as the blaNDM enzyme. Detection of CHDLs produced
by Acinetobacter by MHT has always been a challenge due to
the relative weak activity of enzymes and low membrane per-
meability of the organism. Unsatisfactory CHDL detection by
MHT, including those produced by blaOXA−23, blaOXA−24, and
blaOXA−58, has been documented (Bonnin et al., 2012). Previous
studies have also shown that false negative results of MHT in
detection of blaNDM in Acinetobacter and Enterobacteriaceae
were not uncommon, which may be due to the variation in
zinc content in MHA produced by diﬀerent suppliers (Pasteran
et al., 2011; Girlich et al., 2012). Although performance of P.
aeruginosa ATCC27853 as indicator strain in MHT to detect cer-
tain P. aeruginosa MBLs has been attempted by another group
which reported a low sensitivity and speciﬁcity (Pasteran et al.,
2011), our data conﬁrmed that the use of MHT–PAO1 can suc-
cessfully identify the enzymes encoded by blaIMP, blaNDM, and
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TABLE 2 | Summary of genotypic and phenotypic characteristics of 106 Gram-negative bacterial isolates tested in this study.
Bacterial species tested
(Carbapenemases)
Meropenem
MIC(μg/ml)
No. of isolates No. of positive Modified Hodge Test (MHT)
Pseudomonas aeruginosa
PAO1
Escherichia coli
ATCC25922
P. aeruginosa
blaIMP
blaKPC
Not Detected
≥32
≥32
16 – ≥32
3
1
28
3
1
7
3
0
2†
P. otitidis
blaPOM 16 – ≥32 4 4 0
Acinetobacter baumannii
blaOXA−51like
ISAba1 + blaOXA−51like
blaOXA−51/23like
blaOXA−51/24like
blaOXA−51like + blaNDM
<0.5
8
8 – ≥32
≥32
≥32
14∗
3
49
1
1
0
3
43
1
1
0
0
16†
0
0
Enterobacter cloacae
blaNDM + blaKPC 16 1 1 1
E. coli
blaNDM 16 1 1 0
Total 106 63 22
∗Carbapenem-susceptible. †Also positive in MHT–PAO1 test.
TABLE 3 | Categorization of carbapenem susceptibility phenotypes.
Category Carbapenem
susceptibility
phenotypes
MHT
(E. coli)
MHT-
PAO1
PCR-
genotyping
Implication Examples
I S – – + The carbapenemase gene detectable by genotyping
does not produce carbapenemase
14 carbapenem sensitive A. baumannii
strains harboring the blaOXA−51 like
gene
II R – – – Carbapenem resistance not due to carbapenemase 21 carbapenem resistant P. aeruginosa
strains
III R +/– + – Carbapenem resistance due to a combination of
resistance mechanisms including an unknown
carbapenemase or overexpression of AmpC
Seven P. aeruginosa strains
IV R + + + Carbapenem resistance due to carbapenemase
encoded by the gene detectable by genotyping
Various P. aeruginosa and A. baumannii
strains
V R – + + Carbapenem resistance due to a combination of
resistance mechanisms including a weakly detected
carbapenemase
P. otitidis and A. baumannii strains with
a meropenem MIC ≥32 μg/ml
VI I – + + Carbapenem resistance due to a weakly detected
carbapenemase encoded by the gene detectable by
genotyping
Three A. baumannii strains harboring
the ISAba1+ blaOXA−51like elements
Categorization according to results of the two-tiered MHT tests and genotyping of carbapenemase genes. S, carbapenem sensitive; R, carbapenem resistant; I,
intermediate or low level carbapenem resistance.
blaPOM in P. aeruginosa, E. coli, and P. otitidis, respectively.
Currently, testing carbapenemase activity by MHT or other
assays has been widely used to determine the carbapenem resis-
tance potential of clinical Gram-negative bacterial pathogens to
guide the treatment decision. False negative detection of CHDLs
by traditional MHT may result in wrong diagnosis and inef-
fective treatment. The improved two-tiered MHT can achieve
much less false negative, around 9% (6/64) in isolates carrying
known carbapenemase genes compared to 71% (45/64) by MHT
test, suggesting the high reliability of the two-tiered MHT in
the clinical screening of carbapenem-resistant Gram-negative
pathogens in particular CHDL producers. If the discrepancy in
results of conventional MHT and MHT–PAO1 observable in
this study is indeed due to the low enzyme levels as discussed
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above, future research eﬀorts should be focused on investigat-
ing the underlying basis of high level carbapenem resistance in
organisms producing less active carbapenemase.
Findings of this study allow us to systematically categorize the
test strains according to their carbapenem susceptibility pheno-
types and results of the MHT and genotyping tests. As shown in
Table 3which lists the scenarios which give rise to at least six pos-
sible combinations of the phenotypic and genotypic test results,
we can not only better deﬁne the relative role of each carbapene-
mase in the production of a resistance phenotype on the basis of
the test results, but also identify strains whose resistance pheno-
types were also due to other resistance mechanisms. For example,
if a highly resistant strain with positive genotyping result is found
to produce a weakly detected carbapenamase (positive in MHT–
PAO1 test), it is likely that the resistance phenotype is due to
multiple mechanisms including production of active carbapen-
emase. Here we showed that 34% of the clinical carbapenem
resistant P. aeruginosa strains tested were at least partially due
to carbapenemase, yet the corresponding rate for A. baumannii
was as high as 89%. Detailed delineation of the molecular basis of
carbapenem resistance in these Gram-negative pathogens, which
were previously not possible to perform on the basis of a single
phenotypic or molecular test, shall greatly facilitate development
of novel strategies to treat bacterial infections, especially those
aimed at devising a carbapenemase inhibition approach.
Conclusion
A two-tiered MHT approach which conferred two levels of sen-
sitivities for carbapenemase detection can be applied alongside
PCR genotyping of known carbapenemase genes to determine the
degree of contribution of speciﬁc carbapenemase in expression
of phenotypic carbapenem resistance in Gram-negative bacterial
pathogens. This analytical approach therefore facilitates catego-
rization of carbapenem resistance phenotypes and identiﬁcation
of the major mechanisms concerned in bacterial species in which
clinical carbapenem resistance is common.
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